| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 587,420 | 1,650,285 | 1,564,589 | 1,625,765 | | Cost of Revenue | 1,022,249 | 2,117,910 | 1,856,493 | 1,849,412 | | | Gross Profit | (434,829) | (467,625) | (291,904) | (223,647) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,896 |
-
|
-
|
-
| | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (461,725) | (467,625) | (291,904) | (223,647) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 713 | (713) | 6,446 | | Earnings Before Interest And Taxes | (512,246) | (479,725) | (294,591) | (215,227) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (512,246) | (479,725) | (294,591) | (215,227) | | Income Tax Expense | 2,572 | (141,560) | (14,204) | (56,810) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (514,818) | (338,165) | (280,387) | (158,417) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (514,818) | (338,165) | (280,387) | (158,417) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($514,818) | ($338,165) | ($280,387) | ($158,417) |
|
0.45% Nasdaq 
0.20%
Income Statement
